News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MIV Therapeutics Inc. (MIVT) Announces Participation at TCT 2008 in Washington, D.C.



10/9/2008 12:45:29 PM

ATLANTA & FRANKFURT, Germany--(BUSINESS WIRE)--MIV Therapeutics, Inc. (OTCBB:MIVI) (Frankfurt:MIV), a leading developer of next-generation coatings and advanced drug-delivery systems for cardiovascular stents and other implantable medical devices, announced today its participation at the Transcatheter Cardiovascular Therapeutics (TCT) 2008 conference. The conference will be held on October 12-17 at the Washington Convention Center in Washington, D.C.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES